Pharma Promotional Spending in 2013: Professional Detailing, eDetailing, DTC Advertising, Professional Meetings, Journal Advertising
According to the latest Cegedim Strategic Data (CSD) Audit, the 20 pharma companies that spent the most on total promotion -- which includes traditional professional detailing, eDetailing, Direct-to-Consumer (DTC) advertising, professional meetings, and journal advertising -- spent a total of $14,784 Bn in 2013. This article analyzes data from several sources to determine how much of this is allocated to various media and channels and also looks at the trends for several channels.
Pharma Marketing News Vol. 13, No. 5: May 2014
Welcome to Volume 13, Issue #5 (May 2014) of Pharma Marketing News.
Is FDA Seeing What We’re Seeing with Its Old-School Web Browsers? Klick Health Wants...
In comments submitted to the FDA regarding recent social media guidance (read "FDA Publishes First Piece of Long-Awaited Social Media Guidance" for background), Klick...
What Pharma Can Learn from the CPG Industry About Social Media: If You “Like”...
The social networking savvy of consumer packaged goods (CPG) industry is often cited by pharma marketing consultants as something the pharmaceutical industry should emulate.
Here's...
Digital Health Coalition Urges FDA to Launch a Social Media “Laboratory” to Ensure Adequate...
In comments submitted to the FDA regarding recent social media guidance (read "FDA Publishes First Piece of Long-Awaited Social Media Guidance" for background), the...
BIO Mimics PhRMA’s Comments to FDA Regarding Recent SM Guidance But Is More Polite...
In its opening remarks in comments submitted to the FDA regarding recent Draft Guidance ("Guidance for Industry: Fulfilling Regulatory Requirements for Postmarketing Submissions of...
More Free Rx Drug Samples, More Branded Drug Prescriptions. Duh!
According to a study published today in JAMA Dermatology, branded and branded generic drugs (products that have novel dosage forms of off-patent products or...
PhRMA Questions Legality of FDA’s Recent Social Media Guidance
The FDA received about 20 comments from representatives of the pharmaceutical industry, In my last post, I summarized the comments submitted by Novartis (see...
Delete This and Delete That, Says Novartis to FDA Regarding Recent Social Media Guidance
The comments are in! As usual, the pharma industry waited until the last second to submit comments to FDA Docket 2013-N-1430 regarding "Guidance for...
Total Prescriptions Written & Per Capita Spending in U.S. Rise in 2013
According to a new report issued today by the IMS Institute for Healthcare Informatics, total spending on U.S. medicines increased 1.0 percent on a...
